VertiFlex Inc.’s PMA for the Superion interspinous spacer will be considered by FDA’s Orthopaedic and Rehabilitation Devices Panel on Dec. 12. The agency announced the scheduled meeting on Sept. 19.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?